Skip to main content
. Author manuscript; available in PMC: 2018 Dec 4.
Published in final edited form as: Mol Pharm. 2017 Nov 15;14(12):4685–4693. doi: 10.1021/acs.molpharmaceut.7b00775

Figure 2.

Figure 2

Inhibition studies of five potential hPepT1 substrates on the uptake of GlySar. (A) 10 µM of 3H-GlySar was incubated with a series concentration of inhibitors at room temperature for 2 min, the percent uptake calculated (relative to control), and the results then fit to a dose-dependent inhibition model using Prism version 7.0 (mean ± SE, n = 3). (B) Experimentally confirmed ligands with (a) compound referring to the name of the compound; (b) 2D Sketch representing the two-dimensional structure of the compound; (c) IC50 referring to the experimental IC50 of each compound. The ranking of these compounds in their respective screens is provided in Table S1.